MOUNTAIN VIEW, Calif., Feb. 27, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will feature its award-winning platform of solutions at the HIMSS18 Conference & Exhibition, taking place March 5-9 in Las Vegas. Omnicell's industry-leading medication management platform leverages automation and predictive analytics to improve patient safety, simplify workflows, and decrease costs across health systems.
According to a recent report from the PwC Health Research Institute, three-quarters of healthcare executives plan to invest in artificial and predictive intelligence in the next three years.i Although applying these technologies to medication management in the hospital can help reduce the impact of drug shortages and price increases, only 20 percent of respondents believe they have the ability to implement and achieve success with this technology. Omnicell helps healthcare facilities maximize the benefits of such technology investments, leveraging real-time, cloud-based reporting, analytics, and benchmarking to drive more strategic decision making, while freeing up time for healthcare providers to refocus from administrative tasks to making clinical contributions.
Omnicell's analytics tools and workflow solutions will be on display at HIMSS18 in booth #1629. These include:
- Omnicell Performance Center™ improves business and patient outcomes by combining a cloud-based predictive intelligence platform with ongoing optimization services. This unique approach helps improve medication management by monitoring data across the health system and recommending actions to help optimize medication inventory, proactively manage medication shortages and expiration risk, and reduce overall medication expense.
- Omnicell Analytics is an easy-to-use, web-based diversion analytics software, designed to transform real-time data into actionable insight to help detect potential drug diversion more efficiently.
- XT Series Automated Medication Dispensing Cabinets help improve workflow efficiency, medication accountability, and patient safety through the latest hardware technology and smart software features, including interoperability with leading electronic health record (EHR) systems, diversion analytics and comprehensive controlled substance management. Omnicell's automated dispensing cabinets have received the highest ranking from KLAS for 12 years in a row.
For the first time at HIMSS, Omnicell will be featuring the recently announced Omnicell® XR2 Automated Central Pharmacy System and Omnicell IVX Workflow. The XR2 system uses robotic technology to eliminate numerous manual tasks, allowing pharmacy to redirect resources to clinical activities that have meaningful impacts on patient outcomes. By automating critical workflows in the central pharmacy, XR2 helps drive efficiencies, minimize human error, and enable more accurate management of inventory levels.
IVX Workflow is an innovative sterile compounding workflow solution that incorporates integrated barcode scanning, gravimetric or volumetric verification, advanced image recognition, photo documentation, and label printing as part of a compact all-in-one package. It is designed to support safe, accurate, and streamlined IV sterile compounding. IVX Workflow is powered by Omnicell® IVX Cloud, a web-based software suite designed to manage all aspects of IV compounding workflow operation across a hospital or health system.
In addition, Omnicell will be hosting a reception and panel discussion titled "Digital Transformation Using Interoperability, Machine Learning and Predictive Analytics in the Healthcare Environment with the Impact on Medication Safety" on Tuesday, March 6 from 6 p.m.–8 p.m. at the Venetian Sands Convention Center, Room 201.
Scheduled panelists include:
Dr. Shafiq Rab, MD
Senior Vice President, Chief Information Officer, Rush University Medical Center
Dennis DeMasie
Vice President, Information Technology, Chief Information Officer, Rush Copley
Dr. Eric A. Williams, MD
Chief Medical Information Officer, Texas Children's Hospital
Gee Mathen
Assistant Director Application and Technical Services Pharmacy, Texas Children's Hospital
Glenn George
Applications Architect, Texas Children's Hospital
Moderated by:
Ken Perez
Vice President of Healthcare Policy, Omnicell
RSVP at www.omnicell.com/HIMSS18reception
Omnicell's Performance Center will also be featured in the Interoperability Showcase, located on Level 1 in Hall G. Omnicell will partner with Epic, B Braun, GuardRFID, and Philips in a Use Case titled "Diabetes and Cardiovascular Risk Factors." The case follows individuals with multiple comorbidities, such as diabetes and heart disease, as they face challenges moving through the healthcare system.
"As hospitals continue to look for ways to raise the level of care, we are proud to offer our hospitals and health system partners a broad portfolio leveraging the latest innovative technologies that can be integrated throughout their facilities," said Nhat H. Ngo, executive vice president, marketing, strategy & business development at Omnicell. "We're excited to be at HIMSS18 and showcase how we can work with healthcare providers to reduce manual processes, allowing them to maximize their resources and help positively impact patient outcomes."
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.
Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
For more information about Omnicell, Inc. please visit www.omnicell.com.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
iHealthcare IT News. "Here are the 12 healthcare issues that will define 2018, according to PwC." (Accessed 2/15/18). http://www.healthcareitnews.com/news/here-are-12-healthcare-issues-will-define-2018-according-pwc
View original content with multimedia:http://www.prnewswire.com/news-releases/omnicells-industry-leading-medication-management-automation-platform-and-solutions-to-be-featured-at-himss18-300604827.html
SOURCE Omnicell, Inc.
Betsy Martinelli, Omnicell, Inc., (724) 741-8341, betsy.martinelli@omnicell.com; or Jessika Parry, Next Step Communications, (781) 326-1741, omnicell@nextstepcomms.com
Back to Press Release
Download PDF
